Topoisomerase IIα controls the decatenation checkpoint

[1]  Péter Lénárt,et al.  Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1. , 2008, Developmental cell.

[2]  Iha Park,et al.  Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. , 2006, Experimental cell research.

[3]  S. Jackson,et al.  gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes. , 2006, DNA repair.

[4]  D. J. Clarke,et al.  A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. , 2006, Genes & development.

[5]  T. Bestor,et al.  Decatenation checkpoint deficiency in stem and progenitor cells. , 2005, Cancer cell.

[6]  J. Mata,et al.  Methylation of Histone H4 Lysine 20 Controls Recruitment of Crb2 to Sites of DNA Damage , 2004, Cell.

[7]  Tom J. Petty,et al.  Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks , 2004, Nature.

[8]  K. Yanagisawa,et al.  Identification of Decatenation G2 Checkpoint Impairment Independently of DNA Damage G2 Checkpoint in Human Lung Cancer Cell Lines , 2004, Cancer Research.

[9]  Junjie Chen,et al.  Phosphopeptide Binding Specificities of BRCA1 COOH-terminal (BRCT) Domains* , 2003, Journal of Biological Chemistry.

[10]  James J. Yoo,et al.  Cell cycle checkpoint function in bladder cancer. , 2003, Journal of the National Cancer Institute.

[11]  Michael B Yaffe,et al.  BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting , 2003, Science.

[12]  Georges Mer,et al.  The BRCT Domain Is a Phospho-Protein Binding Domain , 2003, Science.

[13]  S. Mateos,et al.  DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193. , 2003, Mutation research.

[14]  J. Berger,et al.  Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Oshima,et al.  The G2-phase decatenation checkpoint is defective in Werner syndrome cells. , 2003, Cancer research.

[16]  Junjie Chen,et al.  Mediator of DNA Damage Checkpoint Protein 1 Regulates BRCA1 Localization and Phosphorylation in DNA Damage Checkpoint Control* , 2003, The Journal of Biological Chemistry.

[17]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[18]  R. Paules,et al.  ATR Enforces the Topoisomerase II-dependent G2 Checkpoint through Inhibition of Plk1 Kinase* , 2002, The Journal of Biological Chemistry.

[19]  R. Paules,et al.  The human decatenation checkpoint , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Sehested,et al.  Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform. , 1999, Cancer research.

[21]  N. J. Wells,et al.  Casein Kinase II Stabilizes the Activity of Human Topoisomerase IIα in a Phosphorylation-independent Manner* , 1998, The Journal of Biological Chemistry.

[22]  Y. Inoue,et al.  Identification of the Structural Gene for Glyoxalase I from Saccharomyces cerevisiae* , 1996, Journal of Biological Chemistry.

[23]  K. Kimura,et al.  Phosphorylation-independent Stimulation of DNA Topoisomerase II Activity (*) , 1996, The Journal of Biological Chemistry.

[24]  D. J. Clarke,et al.  A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells , 1994, Nature.

[25]  N. J. Wells,et al.  Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitro. , 1994, The Journal of biological chemistry.

[26]  C. Holm.  Coming undone: How to untangle a chromosome , 1994, Cell.

[27]  J. Wang,et al.  Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. J. Clarke,et al.  Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. , 1993, Journal of cell science.

[29]  D. Botstein,et al.  DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage , 1989, Molecular and cellular biology.

[30]  N. Osheroff,et al.  Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. J. Clarke,et al.  Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity , 2000, Chromosoma.